SCHEMBL10051248

SCHEMBL10051248

c1ccc(-c2cc(-c3ccc(-c4cnc5ccccc5c4)cc3)nc(-c3ccc(-c4ccc(-c5nc(-c6ccccc6)cc(-c6ccc(-c7cnc8ccccc8c7)cc6)n5)cc4)cc3)n2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 3/20 0.60
PDGFRA P16234 3/20 0.60
CYP2A6 P11509 1/20 0.57
BIRC5 O15392 1/20 0.55
CA12 O43570 1/20 0.55
CA1 P00915 1/20 0.55
CA2 P00918 1/20 0.55
CA9 Q16790 1/20 0.55
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
ALDH1A1 P00352 2/20 0.54
MAPT P10636 2/20 0.54
HPGD P15428 2/20 0.54
NTSR1 P30989 1/20 0.54
PIK3CD O00329 2/20 0.54
PIK3CA P42336 2/20 0.54
PIK3CB P42338 1/20 0.54
MTOR P42345 1/20 0.54
PIK3CG P48736 1/20 0.54
MAP4K4 O95819 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12210984 1.00 PDGFRB (0.60) PDGFRBPDGFRACYP2A6BIRC5CA12
SCHEMBL10051353 1.00 PDGFRB (0.60) PDGFRBPDGFRACYP2A6BIRC5CA12
SCHEMBL17945820 1.00 PDGFRB (0.60) PDGFRBPDGFRACYP2A6BIRC5CA12
SCHEMBL12579298 1.00 PDGFRB (0.60) PDGFRBPDGFRACYP2A6BIRC5CA12
SCHEMBL10051347 1.00 PDGFRB (0.60) PDGFRBPDGFRACYP2A6BIRC5CA12
SCHEMBL17944732 1.00 PDGFRB (0.60) PDGFRBPDGFRACYP2A6BIRC5CA12
SCHEMBL12210894 1.00 PDGFRB (0.60) PDGFRBPDGFRACYP2A6BIRC5CA12
SCHEMBL10051249 1.00 PDGFRB (0.60) PDGFRBPDGFRACYP2A6BIRC5CA12
SCHEMBL10051319 0.97 PDGFRB (0.56) PDGFRBPDGFRACYP2A6BIRC5CA12
SCHEMBL10051214 0.97 PDGFRB (0.56) PDGFRBPDGFRACYP2A6BIRC5CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120104941-A1 COMPOUND FOR AN ORGANIC PHOTOELECTRIC DEVICE AND ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME CHEIL INDUSTRIES, INC. (KR) 2012-05-03 US disclosed
US-20120104941-A1 COMPOUND FOR AN ORGANIC PHOTOELECTRIC DEVICE AND ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME CHEIL INDUSTRIES, INC. (KR) 2012-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120104941-A1 COMPOUND FOR AN ORGANIC PHOTOELECTRIC DEVICE AND ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME PPOX, TYR, VDAC3 PDGFRB 4380/4885PDGFRA 3688/4885CYP2A6 420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.